Safety profile of blockbuster blood thinner comes under question

A new investigation has raised fresh questions about a bestselling prescription medication to reduce stroke risk in those with the heart rhythm disorder known as atrial fibrillation.



via L.A. Times - Science http://ift.tt/1mGqHBO